Microarrays

Executive Summary

Microarrays Inc. is a specialized biotechnology company founded in 1996 and headquartered at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. The company offers comprehensive microarray-based lab services and custom array printing for DNA, protein/peptide, and antibody/antigen applications, serving the research and diagnostics sectors. Its product portfolio includes the MI PathArray, and it emphasizes quality control and FDA compliance in assay development. As a private, established firm, Microarrays benefits from the growing demand for genomic and proteomic analysis in personalized medicine and diagnostic testing. However, the company faces competition from next-generation sequencing technologies and has not disclosed recent funding or growth milestones, suggesting a stable but niche market position without significant near-term expansion catalysts.

Upcoming Catalysts (preview)

• Q1 2027Partnership with diagnostic company for custom microarray manufacturing25% success
• Q4 2026Launch of new diagnostic array panel for infectious disease detection20% success